Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes
Latest Top (15) News
Blood Pressure Control Target in Diabetes Condition: Blood Pressure Control Target in Diabetes Intervention: Other: Treatment strategy regarding different systolic BP goals Sponsor: Shanghai Jiao Tong University School of Medicine Not yet recruiting
Thu, 17 Jan 2019 12:00:00 EST DIA_CENTRAL:T2D Treatment Pattern in Central Europe Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Empagliflozin; Drug: Sodium Glucose Transporter 2 inhibitor; Drug: Dipeptidyl-peptidase 4 inhibitor; Drug: Glucagon-like peptide 1 agonist Sponsor: Boehringer Ingelheim Not yet recruiting
Thu, 17 Jan 2019 12:00:00 EST Obesity and Endogenous Oxalate Synthesis Conditions: Obesity; Kidney Stone Interventions: Other: Normal Individuals; Other: Calcium Oxalate Kidney Stone Formers; Other: Type 2 Diabetes; Other: Type 2 diabetic kidney stone formers Sponsors: University of Alabama at Birmingham; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Thu, 17 Jan 2019 12:00:00 EST Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study Condition: Lower Urinary Tract Symptoms Intervention: Other: None- Observational Study Sponsors: Arbor Research Collaborative for Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Michigan; Northwestern University; Duke University; University of Iowa; University of Washington; Washington University School of Medicine Completed
Wed, 16 Jan 2019 12:00:00 EST Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect Conditions: Diabetes Mellitus, Type 2; Metabolic Syndrome Interventions: Dietary Supplement: Intervention A; Dietary Supplement: Intervention B; Dietary Supplement: Intervention C; Dietary Supplement: Intervention D Sponsors: German Institute of Human Nutrition; Beneo GmbH Recruiting
Wed, 16 Jan 2019 12:00:00 EST Short or Long Antibiotic Regimes in Orthopaedics Conditions: Osteomyelitis; Prosthetic Joint Infection; Diabetic Foot Interventions: Other: Shorter Systemic Antibiotics; Other: Standard treatment Sponsor: Oxford University Hospitals NHS Trust Not yet recruiting
Tue, 15 Jan 2019 12:00:00 EST Can Brisk Walking Combined With Ingestion of a Lipid-lowering Drug Improve Fat Metabolism in Muscle? Condition: Pre Diabetes Interventions: Diagnostic Test: Body Composition; Diagnostic Test: Maximal aerobic fitness test; Diagnostic Test: Oral glucose tolerance test; Other: Muscle biopsy; Other: Blood samples Sponsors: Liverpool John Moores University; Diabetes UK; Aintree University Hospitals NHS Foundation Trust; Royal Liverpool University Hospital Not yet recruiting
Tue, 15 Jan 2019 12:00:00 EST Continuous Glucose Monitoring in Diabetes and Prediabetes Conditions: Diabetes Mellitus, Type 2; PreDiabetes; Obesity Intervention: Device: DEXCOM G6 RT-CGM Sponsors: Nicole Ehrhardt, MD; DexCom, Inc. Recruiting
Tue, 15 Jan 2019 12:00:00 EST Information, Networks and Rewards to Optimise Adherence to Diabetic Services Condition: Diabetes Interventions: Behavioral: cash rewards for the fellow up; Behavioral: Showing retinal photos to participants; Behavioral: SMS reminders for participants and their family; Behavioral: Watching brief video and basic explanation for disease; Behavioral: Having the Diabetic Club Sponsors: Sun Yat-sen University; Yangxi people hospital, Yangjiang, Guangdong Province Not yet recruiting
Tue, 15 Jan 2019 12:00:00 EST Prognostic Predictors of Response to Hypoglycemic Therapy Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Automatic system guided treatment; Drug: Standard treatment Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health Recruiting
Tue, 15 Jan 2019 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Fri, 21 Dec 2018 10:37:00 -0500 FDA approves first treatment for rare blood disease The FDA approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older.
